Ophthalmic Mergers and Acquisitions Reports
Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic and orthopedic industries.
COMING
SOON
2020 Ophthalmic Deals Book: Mergers and Acquisitions, Financing, and Business/Technology Sales, January, 2021
The “2020 Ophthalmic Deals Book” analyzes investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.
The report covers investments in ophthalmic ventures in 2019 and 2020, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.
2018/2019 Ophthalmic Deals Book: Mergers and Acquisitions, Financing, and Business/Technology Sales, December, 2019
This report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market. The information covers investments in ophthalmic ventures in 2018 and the first 10 months of 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings.
The primary purpose of this report is to analyze investments in ophthalmology and provide information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.
Want to Purchase the Full Report?
Already Have an Account?
Register A Corporate Account
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.